Product information and disease descriptionProduct descriptionProduct information
Special populations
4 evidence topics · 3 sources
Pediatric use: UK paediatric investigation plan waiver granted in all age groups
Age range of the population studied in the European phase Ib/II study
Pregnancy and breastfeeding: excluded, with contraception required of participants
Hepatic and renal laboratory limits applied at screening
Juvenile Huntington's disease
No evidence found.
Dosing in hepatic impairment, renal impairment, or older adults
No evidence found.